AlixaRx receives capital infusion
AlixaRx has received a $100 million investment from Fillmore Capital Partners, the companies said Monday.
AlixaRx also will be spun off from Drumm Corp., the holding company for Fillmore Capital Partners.
The parent company of Golden Living launched Alixa Rx in 2012. It then took over pharmacy services for Golden Living facilities. This was a blow to PharMerica, which lost the contract. In June, Kindred also announced it was breaking with PharMerica to join with Omnicare.